{"nct_id":"NCT00490568","title":"Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers","status":"TERMINATED","status_verified_date":"2017-09","start_date":"2007-08-08","start_date_type":"ACTUAL","primary_completion_date":"2009-06-01","primary_completion_date_type":"ACTUAL","completion_date":"2009-06-01","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}